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1. Introduction 
Integrins are a long family of heterodimeric transmembrane glycoproteins consisting of 
multiple combinations of noncovalently linked α and β chains, which generate different 
complex receptors with different expression patterns and ligand binding profiles. The 
integrins bind to extracellular matrix (ECM) or to cell-surface ligands, regulating numerous 
downstream pathways (Hynes, 2002).  
Each integrin binds to only a limited series of ligands, ensuring that cell adhesion and 
migration are precisely regulated. The α subunit mainly determines the substrate specificity 
with extracellular matrix molecules (ECM) (Yamada, 1991), while the intracytoplasmic tail 
of the β chain is predominantly responsible for the integrin interaction with the cell 
cytoskeleton by binding to vinculin, talin and α-actin (Isenberg, 1991). Thus, this 
heterodimeric association between α and β subunits allows the integrins to act as 
bidirectional signaling molecules in the different tissues and cell types in which they are 
widely distributed, mediating a variety of biological processes so diverse as embryogenesis, 
haemostasis, tissue repair, migration, cell polarity, immune response and metastatic 
diffusion of tumor cells (Hynes, 1987, 1992; Hemler et al., 1994). 
Mammalian integrins have been divided into subfamilies according to their β subunit. The 
most important β integrin subfamilies are β1, β2 and β3. Within a subfamily, the same 
β subunit can associate with different α subunits. To date, 18 α and 8 β chains -whose 
combinations provide up to 24 different integrins- have been described in mammal species 
(Hynes et al., 2002; Alam et al, 2007).  
                                                                 
1The experiments and results showed in this chapter belong to the PhD by G. Esteso directed by J.J. 
Garrido. 
2Sequence data from this article has been deposited with the GenBank Data Libraries under Accession 
No JF808665. 
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The αIIb chain only associates with the β3 chain providing the αIIbβ3 (CD41/CD61) integrin 
receptor which is the most abundant one in platelets. The main role of the  αIIbβ3 receptor is 
the binding of fibrinogen to the surface of the activated platelet, thereby resulting in the 
platelet aggregation with significant consequences in the thrombosis and the homeostasis 
attainment (Clark & Brugge, 1995; Schwartz et al., 1995). Although for a long time it was 
thought that the αIIb integrin expression was limited to platelets and their precursors (the 
megakaryocytes), several studies have revealed  that  the αΙΙb  chains are also expressed in 
myeloid and in hematopoietic cells (Ody et al., 1999; Corbel and Salaun, 2002). In 
addition, αIIbβ3 integrin plays an important role in the progression and invasion of tumors 
(Chen et al., 1992; 1997) and in the differentiation of cells from the myeloid lineage in bone 
marrow (Chen et al, 1997; Wall et al, 1997). In humans, both subunits of the αIIbβ3 integrin 
show a high level of polymorphism resulting in some cases in clinically important 
hemorrhagic disorders (Weiss et al., 1996).  
Consequently, αIIb has been involved in many, different and important functions related 
with platelet activation and tumor progression.  However, most studies related to αIIb 
integrin have been carried out in humans, and little is known about the expression of αIIb 
subunit in porcine tissues and cell types, although pig is generally accepted as an optimal 
experimental model which is used in different areas as immunology, xenotransplantation, 
artherosclerosis, cancer or cardiovascular disease because of its similarity to humans 
(Misdorp, 2003; Lunney, 2007).  
In the present study we describe the cloning and molecular characterization of a cDNA 
encoding the porcine αIIb (CD41) integrin, and the expression pattern of the αIIb mRNAs in a 
variety of porcine cells and tissues. In parallel, we use immunohistochemistry and flow 
cytometry to accurately locate the porcine αIIb integrin protein in the same tissues and cell 
types. For this, we produce a monoclonal antibody against a porcine recombinant αIIb 
protein. We also study if any change is produced in the level of αIIb transcripts in thrombin 
stimulated platelets. Additionally, we identify the chromosomal localization of the porcine 
CD41 gene.  
2. Material and methods 
2.1 Tissues and cells 
Fresh pig blood from approximately 1 year old healthy pigs was collected at the 
slaughterhouse into sodium citrate to final concentration of 10% v/v of the anticoagulant. 
Platelets isolation was carried out according to García et al., 2005. Porcine platelets were 
pelleted from plateled-rich plasma (PRP) obtained by centrifugation at 200g for 20 min of 
blood after addition of ACD solution (117mMsodium citrate, 282mMglucose and 
78mMcitric acid) to a concentration of 7%v/v. The upper third of the PRP was centrifuged 
again after addition of prostacyclin (final concentration 2.5 mM) to avoid platelets 
activation. For platelets activation, the cells were stimulated by the addition of 1 U of 
thrombin for 3min at 37°C. Porcine tissues were recovered from adult pigs immediately 
after slaughtering at the local abattoir and frozen in liquid nitrogen until use. Peripheral 
blood mononuclear cells (PBMC) were isolated from heparinized whole blood using Ficoll-
Hypaque (density 1077 g/ml, Sigma) centrifugation at 900 g for 30 min. Mononuclear cells 
(lymphocytes and monocytes) and granulocytes were collected by aspiration from their 
respective gradient interphases and washed twice in PBS.  
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2.2 RNA isolation, RT-PCR and RACE 
Total RNA from platelets, cells or tissues was purified according to the M-MLV Reverse 
Transcriptase system (Invitrogene) using the random primers pd(N)6-5’-PO3NA+Salt (Pharmacia 
Biotech). RNA samples were kept at –80ºC after controlling the quality on a denaturing 
agarose gel. 5 µg RNA, resuspended in 9.5 µl water, were heated for 3 min at 65ºC in the 
presence of random hexamers (7.5 µM final concentration), and then cooled in ice. RNA was 
reverse transcribed using 1 µl Moloney murine leukemia virus reverse transcriptase (200 
units/µl) (GibcoBRL) for 1 h at 42ºC in a final volume of 20 µl containing 4 µl of 5X reverse 
transcriptase buffer, 0,5 µl ribonuclease inhibitor (50 U/µl) (Roche), 1 µl 20 mM dNTP 
(Pharmacia) and 2 µl 0.1 M dithiothreitol. After 10 min at room temperature, 1 h at 42 º C, and 
10 min at 95ºC, DEPC H2O were added until a final volume of 100 µl. 2 µl of this mixture were 
subjected to PCR using 1µl Tth DNA polymerase (1U/µl) (Biotools) and 2,5 µl each CD41-
specific primer (20µM) (see Table 1) in a final volume of 50 µl containing 5 µl 10x buffer, 2 µl 
MgCl2 (50 mM), and 8 µl dNTP MIX (1,25 mM each) (Biotools). The amplification consisted in 
35 cycles of PCR and each cycle consisted of incubations at 94ºC for 1 min, TmºC for 1 min, and 
72ºC for 1 min. The amplifications were electrophoresed on 1% agarose/1X TAE gel. RT-PCR 
on RNA18S cDNA was used as a control. For RACE (Rapid Amplification of cDNA Ends), 1 
µg total RNA from platelet was used to reverse-transcribe using 1 µl Moloney murine 
leukemia virus reverse transcriptase (200 units/µl) (GibcoBRL) for 1 h at 42ºC in a final volume 
of 20 µl containing 4 µl of 10X reverse transcriptase buffer, 1,0 µl ribonuclease inhibitor (50 
U/µl) (Roche), 4 µl 2,5 mM dNTP (Pharmacia) and 2 µl 3’ RACE ADAPTER (20 µM) in a final 
volume of 20 µL. 3’ CD41 cDNAs were obtained by PCR using a specific porcine CD41 primer 
and the anchor primer provided in the kit (Table 1).  
2.3 DNA sequencing and sequences analysis 
Sequencing was performed using ABI PRISM BigDye Terminator Cycle Sequencing Ready 
Reaction Kit (Applied Biosystems, Foster City, CA, USA) on a thermal DNA cycler GeneAmp 
PCR System 2400 (Applied Biosystems, Foster City, CA, USA), according to the instructions of 
the manufacturer, and analysed on an ABI PRISM 3100 Sequencer (Applied Biosystems, Foster 
City, CA, USA). Porcine CD41 sequence has been deposited at GenBank under number 
JF808665. Sequences were analyzed using the analysis software LaserGene (DNAstar, Londo, 
UK) and the analysis tools provided by the expasy web site <http://www.expaxy.org>. 
Primers design was performed with Oligo 6 (MBI, Cascade, CO, USA) and Amplify 3 
(<http://www.engels.genetics.wisc.edu/amplify/>). Multiple alignment among CD41 
peptide sequences from Sus scrofa (GenBank accession no. JF808665 ), Homo sapiens (GenBank 
accession no. AAI26443), Bos taurus (GenBank accession no. NP_001014929), Mus musculus 
(GenBank accession no. NP_034705), Rattus norvegicus (GenBank accession no. XP001063315), 
Canis familiaris (GenBank accession no.  NP_001003163), Equs caballus (GenBank accession 
no. NP_001075262), Oryctolagus cuniculus (GenBank accession no. Q9TUN4), Danio rerio 
(GenBank accession no.  AAQ82784) and Xenopus laevis (GenBank accession no. Q5XH72) was 
performed by using MUSCLE program (Edgar, 2004). 
2.4 Recombinant CD41 protein (rpCD41) expression and purification  
DNAs encoding extracellular domains of the porcine CD41 were amplified by PCR. Primers 
used for amplification contained restriction sites enabling ligation into the expression vector 
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pET28b (Novagen) following digestion of the PCR product and the vector with BamHI and 
HindIII. Two different pairs of primers were used: F1rp-EcoRI/R1r-pXhoI and F2rp-
BamHI/R2rp-HindIII (Table1). PCR product was ligated into the expression vector pET28b 
and used to transform Escherichia coli strain BL21 (DE3) (Novagen). Recombinant proteins 
(rpCD41-F1R1 and rpCD41-F2R2), expression and purification were carried out following 
previously procedures described by us (Jiménez-Marín et al., 2000).  
2.5 Antibodies production 
A monoclonal antibody, GE2B6, against rpCD41-F2R2 and two polyclonal antibodies, anti-
rpCD41-F1R1 and anti- rpCD41-F2R2, were produced using previously described 
immunization and cells fusion procedures (Arce et al., 2002; Jiménez-Marín et al., 2000). 
Briefly, female BALB/c mice were immunized with 50 µg of rpCD51. Spleen cells from 
immune mice were fused with Sp2/0 myeloma cells. Hybridoma clones were selected on 
the basis of binding secreted antibody to rpCD61 by indirect ELISA. Antibody-producing 
hybridomas reacting positively were cloned at least twice by limiting dilution. 
Immunoglobulin classes and subclasses were determined in solid-phase ELISA using rabbit 
antisera specific for mouse heavy and light chains and a peroxidase-conjugated goat anti-
rabbit immunoglobulin (Sigma). 
2.6 Electrophoresis and immunoblottings 
Platelets (108/sample) were lysated in NP-40 lysis buffer with PMSF 2 mM with vigorous 
shaking for 1 h at 4ºC, and then centrifuged at 12,000 rpm, 20 min. 100 µl supernatant were 
mixed with 100 µl of sample treatment buffer, and 100 µl were loaded in the gel. 
Electrophoresis was carried out in 5%-15% gradient polyacrilamide gels. For the 2D 
electrophoresis, the platelet proteins pellet was resuspended in lyses buffer (7 M urea, 2 M 
thiourea, 4% CHAPS, 1% DTT, 0,8% ampholytes). Immobilized pH gradient strips (17 cm, 5-
8 linear pH gradient, Bio-Rad) were rehydrated with 300 µl (300 µg) of the protein solution 
for 16 h, and focused in a PROTEAN IEFcell (Bio-Rad). Second dimension was performed 
on 10% SDS-PAGE. For the immunoblottings, proteins were transferred from gels to PVDF 
Inmobilon P membranes (Milipore). Membranes were blocked and washed three times in 
PBS-T, and then incubated with 3 ml antibody or PBS as negative control, overnight at 4ºC 
in shaking. After three washing ups in PBS-T, the membranes were incubated with rabbit 
anti-immunoglobulin-peroxidase (Sigma). Afterwards, they were washed up three times in 
PBS-T, and finally reactions were detected with the ECLTM detection system (Amersham) 
following the manufactures instructions. 
2.7 Immunoprecipitation of platelet CD41 proteins 
Platelets (108/sample) were incubated with 0.4 mg sulfobiotin (Pierce) with gently 
shaking for 15 min at 4ºC, and then centrifuged at 3,000 rpm, 15 min. Pellet was washed 
three times in PBS, and then resuspended in lyses buffer (500 µl/sample) and PMSF 2 
mM. After incubation in dark with vigorous shaking for 1 h at 4ºC, it was centrifuged at 
13,000 rpm, 20 min, and the supernatant was collected. 50 µl of protein G-Sepharose 
(Pharmacia) were added per ml of supernatant and incubated with shaking overnight at 
4ºC, and then centrifuged at 2,000 rpm, 5 min. 500 µl lysate were incubated with 1 ml of 
the anti-porcine CD41 antibody for 2 h at room temperature. At the same time, when 
monoclonal antibody was going to be used, to increase its binding ability, the G protein is 
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recovered with an anti-mouse immunoglobulin rabbit serum (Pierce) 1/10 in lyses buffer, 
for 2 h at room temperature. Then, the G protein is washed three times in lyses buffer, and 
centrifuged at 2,000 rpm, 2 min. This step was not needed when polyclonal antibodies 
were used. 50 µl of the antibody recovered G-Sepharose were added to the lysate 
containing the anti-CD41 antibody and incubated for 1 h at room temperature with 
shaking, and then centrifuged at 2,000 rpm, 5 min. The supernatant was collected and 
washed three times in lyses buffer, the first being in buffer and sucrose. Finally, 
supernatant was subjected to SDS-PAGE in 5%-15% gels in reducing or not reducing 
conditions. After electrophoresis, the proteins were transferred to PVDF, Inmobilon P 
membranes, as described before, and, after be blocked, incubated with a solution of 
Streptavidin-HRP (Amersham) solution 1/500 in PBS for 1 h in dark. Then, membranes 
were washed three times in PBS-T and revealed with the ECLTM detection system 
(Amersham) following the manufactures instructions. 
2.8 Immunohistochemistry 
Expression of CD41 protein from healthy animals was studied following previously 
procedures described by us (Jiménez-Marín et al., 2008) using monoclonal antibody GE2B6 
supernatant or polyclonal antibodies (1/3000 dilution in PBS) or an irrelevant mAb (as 
negative control). Briefly, all tissue specimens were fixed in Bouin liquid for 16 hours. 
Tissues were dehydrated in ascending concentrations of ethanol and xylene and embedded 
in paraffin. Sections of 5 µm were placed on slides coated with Vectabound (Vector 
Laboratiores, Inc.). The tissue slides were kept at 55ºC for 45 min to improve the adherence 
of sections to glass. The sections were deparaffinized and rehydrated in xylene and 
descending concentrations of ethanol, respectively. Endogenous peroxidase activity was 
inhibited with 3% hydrogen peroxidase. The sections were incubated with normal goat 
serum (1:10 dilution in PBS) (Vector) for 30 min at room temperature. After removing the 
serum, anti-porcine CD41 antibodies or an irrelevant mAb (as negative control) were added 
for 18 hours at 4ºC in a wet chamber. The sections were incubated with biotinylated anti-
mouse Ig (Dako) diluted 1/50 in PBS for 30 min at room temperature. Tissue sections were 
covered with avidin-biotin-peroxidase complex (Sigma) diluted 1/50 with PBS for 1 h in a 
wet chamber at room temperature, washed and then developed with 3, 3’-diaminobenzidine 
(Sigma) (5 µg in 10 ml PBS). Sections were counterstained with Mayer hematoxylin and 
mounted with Eukitt.  
2.9 Flow cytometry 
100 µl of platelets (106 cells/ml) and 100 µl of the antibody (or PBS as a control) were 
incubated 30 min at 4ºC. After washing with PBS, tubes were centrifuged at 3,000 rpm, 6 
min, and the platelets resuspended in 50 µl of a rabbit FITC-anti-immunoglobulin (1/160 in 
PBS) (Sigma). After incubation at 4ºC 30 min in dark, the platelets were washed three times 
in PBS and the fixed in 1% PFA/PBS. Samples were analyzed in a FACsort cytometer 
(Bencton Dickinson) equipped with a CellQuest v 1.2software. 
2.10 Chromosome localization 
The INRA somatic cell hybrid panel (Yerle et al., 1996) was screened with porcine primers 
(VARP1 and VARP2), which specifically amplify a 212 bp fragment (Table 1). For 
genotyping of the hybrid panel, 10 ng of DNA from each cell line and control sample (pig, 
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hamster, and mouse) were amplified. PCR products were evaluated on a 1% agarose gel and 
individual cell lines were evaluated for the presence or absence of a fragment of the correct 
size. Statistical calculations of the assignment were performed using the software developed 
by Chevalet et al (1997) (<http://www.inra.toulouse.fr>). The INRA-Minesota porcine 
radiation hybrid (IMpRH) panel (Yerle et al., 1998; Hawken et al., 1999) was screened with 
the same porcine specific primers in the same PCR conditions (Table 1). Statistical 
calculations of the assignment were performed using the IMpRH mapping tools 
(<http://www.imprh.toulouse.inra.fr>). 
2.11 Quantitave real time RT-PCR 
CD41 cDNA was quantified by real time quantitative PCR (RT-Q-PCR) relative to β-
actin cDNA reverse transcribed from total RNA from platelets. The PCR reaction was 
carried out with 0.5 µl of each VARP1/VARP2 and β−actinF/ β-actinR primers (Table 1) 
(20µM), 12.5 µl of iQTM SYBR1 Green Supermix (Bio-Rad), and 1.5 µl of the cDNA 
sample. The PCR conditions included 40 cycles of 30s at 94ºC, 30s at 60ºC and 30s at 
72ºC. All experiments were performed three times to confirm accuracy and 
reproducibility of real-time PCR. The efficiency of the primers (E) was calculated 
according to the equation (1).  
 E = 10[-1/p]  (1) 
being p the slope of the standard curve log(fluorescence)/Ct.  
The relative abundance of CD41 gene expression was determined by the ratio (R) 
equation (2) 
  R=2[∆Ct (target)-∆Ct (control)]   (2) 
being Ct = threshold cycle (cycle at with PCR amplification reaches a significant value). 
3. Results  
3.1 Cloning and sequence analysis of the porcine CD41 cDNA 
The porcine full length CD41 cDNA was obtained by a combination of PCR and RACE 
(Rapid Amplification of cDNA Extremes). A partial sequence that lacked the 3’ cDNA 
extreme, including part of the coding sequence, was deposited in GenBank (AF170526). 
So, we first amplified the pig CD41 5’ cDNA using forward and reverse primers 
designed from this sequence. Three pairs of primers were used P3/R4, P1/R2 and F1/R1 
(Table1).  
Three 1352, 870 and 677 bp long overlapping fragments were produced, respectively.  
Altogether, the three fragments provided a 2701 bp long sequence that belongs to the 5’ 
extreme of the CD41 cDNA (Figure1). To obtain the remaining 3’ sequence of the CD41 
cDNA we carried out a RACE by using the RACE-out and the RACE-P5 primers shown in 
Table1. This allowed us to obtain an additional 622 bp long 3’ sequence (Figure1). Finally, 
we obtained the full length CD41 cDNA molecule amplifying RNA from platelets by RT-
PCR by using the FcDNA5 and RcDNA3 pair of primers (Table1 and Figure1) and MBLong 
polimerase. 
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Primers Primer sequences 5’- 3’    Template,  localization (5’-5’) 
Product 
size (bp) 
Tm 
(ºC) 
FP3 TGTGGAAGAAGGAAGATGG 
cDNA, 2-1353 1352 58.1 
RP4 GCAGAGCCTGCGGCAAAGG 
FP1 GGGCCAAGTATCGGTGTTC 
cDNA, 1264-2133 870 60.0 
RP2 TGGGTACAGATGAGCCTCTCTAAG 
F1 CCCCAGGTGCTCACTACA 
 cDNA, 2066- 2742 677 60.0 
R1 TCGGCAGCTCAGGAGAATTGGA 
RACE-adapter GCGAGCACAGAATTAATACGACTCACTATAGGT12 
   
RACE-outer GCGAGCACAGAATTAATACGACT 
cDNA, 2638-3’ 622 60.0 
RACE-P5 CTCCCCTGTGTACCCAGCTCATCA 
FcDNA5 CCTAAGCTTAAGATGGCCAGAGCTTTGTGT 
cDNA, 13-3125 3113 59.2 
RcDNA3 GCAAAGCTTTCACTCCTCCTCTTCATCAGA 
VARP1 GAGGCATGACCTCTTGGTGG Genomic DNA 
cDNA, 1012-1223 212 59.0 VARP2 CATTGTAGCCATCCCGGTTC 
F1rp-EcoRI CGACGAATTCCCCCAGGTGCTCACTACA 
 cDNA, 2066- 2742 677+20 60.0 
R1rp-XhoI CGACTCGAGGCAGCTCAGGAGAATTGGA 
F2rp-BamHI GGTCGGATCCTTGAACCTGGACCCAGTGCAT 
 cDNA, 110-1105 996+20 59.0 
R2rp-HindIII GGTAAGCTTCTGCAGGAACAAGTAAACACG 
 
 
 
 
Table 1. Primers used in PCRs and RACE. 
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Fig. 1. Strategy and localization of the primers used for cloning the porcine full length CD41 
cDNA. 
The full CD41 cDNA was 3336 bp long and contained an open reading frame of 3111 bp 
(Figure2) which encodes a CD41 polypeptide of 1036 amino acid residues, and a 198-bp long 
untranslated 3’ flanking region. The nucleotide sequence encoding the full length CD41 pig 
cDNA was submitted to GenBank (Accession number JF808665). 
The first 31 amino acid residues of CD41 are predominantly hydrophobic and correspond to 
the signal peptide sequence. So, the pig mature pre-CD41 molecule consists of 1005 amino 
acid residues, and, as this amino acid sequence has a proteolytic cleavage site (KR/D) 
located between amino acids residues 899 and 900 in pre-CD41 (Takada et al., 1989), the 
mature porcine CD41 polypeptides –lacking the signal peptide- must be composed by two 
different chains (914 and 91 amino acid residues) linked by disulfide bridges, similar to 
those reported in homologous CD41 integrins. Other sequences and structural domains 
contained in other CD41 proteins are also presents in the porcine CD41 chains (Figure2). 
The seven FG-GAP tandem repeats are shown as W with arrows marking their initial and 
final limits. An α helix is shown in red. The long extracellular domain of the porcine CD41 
integrin consists of 869 amino acids residues. It contains 8 consensus N-glycosylation sites 
(Asn-X-Ser/Thr, where X is not Pro) identified by the NetNGlyc 1.0 program 
(www.expasy.org), and 18 –from 19- cystein   residues. As in other α integrins, the 
extracellular domain of the porcine CD41 contains four Ca++ binding domains 
(DX(D/N)XDGXXD) and seven FG-GAP tandem repeats -which are identified by the 
SABLE 2.0 program (http://sable.cchmc.org/)- each one containing four helixes similar to 
those previously described (Springer, 1997; Xiong et al., 2001). The secondary structure of 
CD41 molecule is shown in Figure3 and the tertiary one, obtained with the Swismodel 
(www.expasy.org), is shown in Figure4.   
The stretch sequence of 26 hydrophobic amino acid residues located in the carboxy-terminal 
portion of the polypeptide must constitute the transmembrane domain. Following it there is 
a short 20-amino acid sequence that must represent the cytoplasmic domain of the molecule. 
It contains a GFFKR (1019-1023 in pre-CD41) domain, which is conserved in all human α 
integrin chains and is involved in the link of both α and β chains of the heterodimeric 
complex (Rojiani et al., 1991). It also contains a β−like turn (PPLEE) (1026-1030), that in 
comparison to the αv chain (PPREE) could aid in the ligand interaction of fibronectin and 
 
1352 bp 870 bp 677 bp RACE 
P3 P1 F1
P4 P2 R1
P5-RACE
RACE-OUTER 
2701 bp 622 bp 
CD41 cDNA 3336 bp/1036 aa
FcDNA53 
RcDNA3
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vitronectin with the intact αIIbβ3 heterodimer which is essential for various transductional 
processes during mammalian organogenesis (Filardo & Cheresh, 1994).  
 
 
 
 
 
 
 
 
           TTGTGGAAGAAGGAAGATGGCCAGAGCTTTGTGTCTACTTCATGCCCTCTGGCTTCTGGAGTGGGTGCAACTGCTCTTG 79 
                            M  A  R  A  L  C  L  L  H  A  L  W  L  L  E  W  V  Q  L  L  L  21 
                          
GGACCCGGTGCTGCCCCTCCAACCTGGGCCTTGAACCTGGACCCAGTGCATCTCACCATCTACACAGGCCCCAATGGCAGCCACTTTGGG 169   
 G  P  G  A  A  P  P  T  W  A  L  N  L  D  P  V  H  L  T  I  Y  T  G  P  N  G  S  H  F  G  51 
                                                                                               
TTTTCATTGGACTTCTACAAGAAGAGCCATGGCAGCGTATCCATCGTGGTGGGGGCCCCGCGGACCTTGGGCCGCAACCTGGAGGAGACC 259   
 F  S  L  D  F  Y  K  K  S  H  G  S  V  S  I  V  V  G  A  P  R  T  L  G  R  N  L  E  E  T  81 
 
GGCGGCGTTTTCCTGTGTCCCTGGAAGGCCAAGAGCGTCCAGTGCGTCGCGCTGTCCTTCAACCTCGATGATGAGACGCGAAACGTAGGC 349   
 G  G  V  F  L  C  P  W  K  A  K  S  V  Q  C  V  A  L  S  F  N  L  D  D  E  T  R  N  V  G  111 
                                                                                     
GCCCAAACTTTCCAAACCTTCAAGGCCCGTCAAGGACTAGGGGCGTCGGTCTTAACTTGGAGAGACAACGTTGTGGCCTGCGCCCCCTGG 439   
 A  Q  T  F  Q  T  F  K  A  R  Q  G  L  G  A  S  V  L  T  W  R  D  N  V  V  A  C  A  P  W  141 
 
CAGCACTGGAACGTCCTAGAAAAGAACGAGGAGGCTGAGAAGACACCTGTAGGTGGCTGCTTCGTGGCTCAGCTCCAGAACAGCGGCCGC 529   
 Q  H  W  N  V  L  E  K  N  E  E  A  E  K  T  P  V  G  G  C  F  V  A  Q  L  Q  N  S  G  R  171 
 
GCGGAGTTCTCGCCCTGTCGGGCCAACCTCTTGAGCCTGGTTTACGTGGAAAGTAAATTCAATGACAGGCGCTATTGCGAGGTCGGCTTC 619   
 A  E  F  S  P  C  R  A  N  L  L  S  L  V  Y  V  E  S  K  F  N  D  R  R  Y  C  E  V  G  F  201 
                                
AGCTCTGCGGTCACTCAGGCTGGGGAGCTGGTGCTTGGGGCTCCTGGGGGCTACTATTTCTTAAGTCTCATGGCACGGGCTCCAATTGCC 709   
 S  S  A  V  T  Q  A  G  E  L  V  L  G  A  P  G  G  Y  Y  F  L  S  L  M  A  R  A  P  I  A  231 
 
GATATCATCTCGAGTTACCGCCCAGGCACCCTCTTGTGGCACGTGCCCACCCAGAAGCTCACCTTCGACTCCGACCTTCCTGAGTACTAC 799   
 D  I  I  S  S  Y  R  P  G  T  L  L  W  H  V  P  T  Q  K  L  T  F  D  S  D  L  P  E  Y  Y  261 
                                                                                         
GAGAGCTACTTGGGGTACTCGGTGGCTGTGGGCGAGTTCGACCGGAATCCCAACACCACAGAGTACATCCTCGGTGGCCCCACCTGGAGC 889   
 
 E  S  Y  L  G  Y  S  V  A  V  G  E  F  D  R  N  P  N  T  T  E  Y  I  L  G  G  P  T  W  S  291 
ATGACCCTGGGAGCGGTGGAAATTTTTACCTCGAAACACCAGAGGCTGCACCTGCTGCAGGGAGAGCAGGTGGCTTCATATTTCGGGCAT 979   
 M  T  L  G  A  V  E  I  F  T  S  K  H  Q  R  L  H  L  L  Q  G  E  Q  V  A  S  Y  F  G  H  321 
                                                                       
TCAGTGGCCGTCACCGACGTCAACGGGGACGGGAGGCATGACCTCTTGGTGGGAGCGCCACTGTACATGGAGAGCCGTGCTGACCACAAG 1069  
 S  V  A  V  T  D  V  N  G  D  G  R  H  D  L  L  V  G  A  P  L  Y  M  E  S  R  A  D  H  K  351 
 
CTGGCCGAGGTGGGGCGTGTTTACTTGTTCCTGCAGTCTCGAGGTCACCACTCGCTGGGCACCCCCAGCCTCCTGCTGACAGGCACACAG 1159  
 L  A  E  V  G  R  V  Y  L  F  L  Q  S  R  G  H  H  S  L  G  T  P  S  L  L  L  T  G  T  Q  381 
 
CTCTATGGACGATTTGGCTCAGCCATCGCGCCTCTGGGCGACTTGAACCGGGATGGCTACAATGATGTTGCCGTGGCCGCCCCCTATGGG 1249  
 L  Y  G  R  F  G  S  A  I  A  P  L  G  D  L  N  R  D  G  Y  N  D  V  A  V  A  A  P  Y  G  411 
     
GGTCCCACCGGTCAGGGCCAAGTATCGGTGTTCCTGGGTCAGAGTGAGGGGCTTAACTCGCAGCCCTCCCAGGTCCTGCACAGCCCCTTT 1339  
 G  P  T  G  Q  G  Q  V  S  V  F  L  G  Q  S  E  G  L  N  S  Q  P  S  Q  V  L  H  S  P  F  441 
 
GCCGCAGGCTCTGCCTTTGGCTTCTCCCTTCGAGGTGCCACAGACATCGATGACAATGGATACCCAGACCTGCTGGTAGGAGCTTACGGG 1429  
 A  A  G  S  A  F  G  F  S  L  R  G  A  T  D  I  D  D  N  G  Y  P  D  L  L  V  G  A  Y  G  471 
     
GCCGACAAGGTTGTCGTGTACCGAGCTCAGCCGGTGGTGACCGCCACTGTCCAGCTGATGGTGCAAGAATCCCTGAATCCTGCTGTGAAG 1519  
 A  D  K  V  V  V  Y  R  A  Q  P  V  V  T  A  T  V  Q  L  M  V  Q  E  S  L  N  P  A  V  K  501 
                                                                          
AATTGTGTCCAGCCCCAAACCAAGACACCAGTGAGCTGCTTTACCATCCAGATGTGTGTGGGAGCCACTGGGCACAACATTCCTGAGAAG 1609  
 N  C  V  Q  P  Q  T  K  T  P  V  S  C  F  T  I  Q  M  C  V  G  A  T  G  H  N  I  P  E  K  531 
 
CTGCGCCTAAATGCCGAGCTGCAGCTGGACCGGCAGAAACCCCACCAGAGCCGGCGGGTGCTGCTGCTGGCTTCCCAACAGGCGAGCACT 1699  
 L  R  L  N  A  E  L  Q  L  D  R  Q  K  P  H  Q  S  R  R  V  L  L  L  A  S  Q  Q  A  S  T  561 
 
GTCCTGGACGTGGATCTGACCTGGAGGCAGAGCCCCACCTGCCACAACACCACGGCCTTCCTCCGGGATGAGGCTGATTTCCGGGACAAG 1789  
 V  L  D  V  D  L  T  W  R  Q  S  P  T  C  H  N  T  T  A  F  L  R  D  E  A  D  F  R  D  K  591 
 
CTGAGCCCCATCGTGCTCAGCTTCAATGTGTCCCTGCAGCCGGAGAAGAATGGAGACGCCCTCACGTTCATGCTGCATGGAGACACCCAC 1879  
 L  S  P  I  V  L  S  F  N  V  S  L  Q  P  E  K  N  G  D  A  L  T  F  M  L  H  G  D  T  H  621 
 
GTTCAGGAACAGACCCGCATCATCCTGGACTGTGGGGAAGACCAAGTGTGCGTGCCAAAGCTCCAGCTCTCGGCCAACACGACAGGCTCC 1969  
 V  Q  E  Q  T  R  I  I  L  D  C  G  E  D  Q  V  C  V  P  K  L  Q  L  S  A  N  T  T  G  S  651 
 
CCACTCCTAGTTGGAGCTGATAATGTGCTGGAGCTGCACGTGGTCGCGGCCAATGAGGGCGAGGGAGCCCATGAGGCCGAGCTGGTTGTG 2059  
 P  L  L  V  G  A  D  N  V  L  E  L  H  V  V  A  A  N  E  G  E  G  A  H  E  A  E  L  V  V  681 
 
CACCTGCCCCCAGGTGCTCACTACATGCAGGCCCTCAGCAACACCAAGAGCTTCGAGAGGCTCATCTGTACCCAGAAGAAGGAGAATGAG 2149  
 H  L  P  P  G  A  H  Y  M  Q  A  L  S  N  T  K  S  F  E  R  L  I  C  T  Q  K  K  E  N  E  711 
 
ACCAAAGTGGTGCTGTGTGAGCTGGGCAACCCCATGAAGGGGGACACCCAGATAGAAATCACGATGTTGGTGAGTGTGGGGAACCTGGAA 2239  
 T  K  V  V  L  C  E  L  G  N  P  M  K  G  D  T  Q  I  E  I  T  M  L  V  S  V  G  N  L  E  741 
 
GAGGCTGGGGAGCACGTGTCCTTCCGGCTGCAGATCAGGAGCAAGAACAGCCAGAATCCAAACAGCGAGACAGTGGTGCTGGATGTGCAA 2329  
 E  A  G  E  H  V  S  F  R  L  Q  I  R  S  K  N  S  Q  N  P  N  S  E  T  V  V  L  D  V  Q  771 
F 2 
R 2 
F 1 
P 3 
P 4
 P 1 
   P 2 
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Fig. 2. The nucleotide and deduced amino acid sequences of pig CD41 cDNA. The predicted 
signal peptide is remarked in light green, the transmembrane domain in dark green, and the 
cytoplasmic region, containing the GFFKR sequence, in purple. The putative 
polyadenylation sequence is remarked in a black box. Potential N-glycosylation sites are 
indicated in red. Cysteine residues are marked as C in yellow. Putative cleavage sites are 
shown as ▲. Ca++ binding domains are remarked in pink. Primers used for cloning are 
marked with arrowheads. 
GTCCGGGCAGAGGCCCACCTGGAGCTGAGAGGGAACTCCTTTCCAGCCTCCCTGTTGATGGCGGCAGAAGGCGATTGGGAGAACAGCTCG 2419  
 V  R  A  E  A  H  L  E  L  R  G  N  S  F  P  A  S  L  L  M  A  A  E  G  D  W  E  N  S  S  801 
 
GACAATTTGGGCCCCAAAGTGGAGCACACCTATGAGCTCCACAACAATGGCCCTAGTACCGTAAGTGGCCTCCACCTCAGGCTCCACCTG 2509  
 D  N  L  G  P  K  V  E  H  T  Y  E  L  H  N  N  G  P  S  T  V  S  G  L  H  L  R  L  H  L  831 
 
CCCGGCCAGTCCCAGACCTCCGACCTGCTCTACATCGTGGACATACAGACCCAGGGAGGCCTTCAGTGCTCCCCGCAGCCCTCTCCCAAC 2599  
 P  G  Q  S  Q  T  S  D  L  L  Y  I  V  D  I  Q  T  Q  G  G  L  Q  C  S  P  Q  P  S  P  N  861 
 
CCCCGCCAGCTGGACTGGGGGCTGCACAGCCCCACACCCTCCCCTGTGTACCCAGCTCATCACAAGCGGAATCGCAGACAGGCAGTCCTG 2689  
 P  R  Q  L  D  W  G  L  H  S  P  T  P  S  P  V  Y  P  A  H  H  K  R  N  R  R  Q  A  V  L  891 
                                                                              
CCAGGGCAGAAGCAGCCGTTGAGTCTTCAGGATCCAATTCTCCTGAGCTGCGACTCGGCGCCCTGCACCGTGGTGCACTGTGACCTTCCG 2779  
 P  G  Q  K  Q  P  L  S  L  Q  D  P  I  L  L  S  C  D  S  A  P  C  T  V  V  H  C  D  L  P  921 
                        
GAGATGGCGCGTGGGCAGCGGGCCATGGTCACCGCGCAGGCTTTCCTGTGGCTGCCCAGCCTCCGCCAGAGACCCCTGGATCAGTTTGTG 2869  
 E  M  A  R  G  Q  R  A  M  V  T  A  Q  A  F  L  W  L  P  S  L  R  Q  R  P  L  D  Q  F  V  951 
 
CTGCGGTCGCACGCTTGGTTCAACGTCTCTTCCCTTCCCTACGCCGTGCCCGCCCTCAGCCTGCCCAGCGGGGAAGCTCAGGTGCAGACA 2959  
 L  R  S  H  A  W  F  N  V  S  S  L  P  Y  A  V  P  A  L  S  L  P  S  G  E  A  Q  V  Q  T  981 
 
CAGGTGCTTCGGGTCTTGGAGGACAGAGAGGTTCCACTCTGGTGGATGCTGGTAGGCGTGCTGGGCGGCCTGCTGTTGCTCACACTGCTG 3049  
 Q  V  L  R  V  L  E  D  R  E  V  P  L  W  W  M  L  V  G  V  L  G  G  L  L  L  L  T  L  L  1011 
 
GTCCTGGCCATGTGGAAGTGTGGCTTCTTCAAGCGGAATCGGCCACCCCTGGAAGAATCTGATGAAGAGGAGGAGTGACGCTGCAGCCCA 3139  
 V  L  A  M  W  K  C  G  F  F  K  R  N  R  P  P  L  E  E  S  D  E  E  E  E  *              1036 
CACATCTCTGTTCCTGCAGAAAGGCTGCATGTGGTGACTGCCCTGTCCCTCTTCTCCAGCCAGTGCCCTGCGAGCTCTGCTCGCCCATGA 3229  
ATTGGAGCTGTTCCCTGGAGGCCTCCCGATGTCCTCCTGCTCCCATCAGAGCTGGCTCACCCCCCTTCCTGCTGCCTAATAAAGAGGCTG 3319  
AACCCCAAAAAAAAAAA                                                                        3336  
   R 2 
P 5 RACE 
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Fig. 3. Secondary structure of the porcine CD41 molecule. Sequences in β antiparallel sheets 
are shown in green.  
 
 
Fig. 4. Three-dimensional structure of the porcine CD41 molecule. The seven FG-GAP 
tandem repeats are shown as W, each one composed by four β antiparallel chains.  
 
               →             W1 
LNLDPVHLTIYTGPNGSHFGFSLDFYKKSHGSVSIVVGAPRTLGRNLEET 
 
                            ←→        
GGVFLCPWKAKSVQCVALSFNLDDETRNVGAQTFQTFKARQGLGASVLTW 
 
                         W2 
RDNVVACAPWQHWNVLEKNEEAEKTPVGGCFVAQLQNSGRAEFSPCRANL 
 
←→                      W3 
LSLVYVESKFNDRRYCEVGFSSAVTQAGELVLGAPGGYYFLSLMARAPIA 
 
                    ←→             W4 
DIISSYRPGTLLWHVPTQKLTFDSDLPEYYESYLGYSVAVGEFDRNPNTT 
 
                               ←→         W5 
EYILGGPTWSMTLGAVEIFTSKHQRLHLLQGEQVASYFGHSVAVTDVNGD 
 
                                                ← 
GRHDLLVGAPLYMESRADHKLAEVGRVYLFLQSRGHHSLGTPSLLLTGTQ 
 
→                      W6 
LYGRFGSAIAPLGDLNRDGYNDVAVAAPYGGPTGQGQVSVFLGQSEGLNS 
 
          ←→                 W7 
QPSQVLHSPFAAGSAFGFSLRGATDIDDNGYPDLLVGAYGADKVVVYRAQ 
 
             ← 
PVVTATVQLMVQESL 
1 2
3 4 1
2 3
1 2 3
1
2 3 4 1
2 3 4
1 2
3 1 2 3
4
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3.2 Comparative analysis 
The deduced protein sequence of the porcine CD41 was compared to their orthologous 
proteins from six different species: humans, cattle, horses, dogs, rats, rabbits, mice, zebrafish 
and xenopus (Figure5 and Table2).  
 
 
 
PIG             MARALCLLHALWLLEWVQLLLGPGAAPPTWALNLDPVHLTIYTGPNGSHFGFSLDFYKKS 60 
HUMAN           MARALCPLQALWLLEWVLLLLGPCAAPPAWALNLDPVQLTFYAGPNGSQFGFSLDFHKDS 60 
HORSE           MARALRPLHALWLLEWMQLLLGPGTAPQAWALNLDPVRLTFYTGPNGSHFGFSLDFYKDS 60 
RABBIT          MARALGPLPAFWFLEWALLLLGPGAGPPAWALNLDPVQLTIYTGLNGSHFGFSLDFYKDS 60 
DOG             MARAVCPLNALWLLEWVQLFLGPGAIPLGWALNLDPVQLTFYTGPNGSHFGFSLDFYKDN 60 
COW             ---------------------------PTWALNLDSVQFTVYTGPNGSHFGFSLDFYKNS 33 
RAT             MARASCAWNTLWLLQWTPLFLGPSAAPPAWALNLDPVKFSVYTGPNGSHFGFSVDFHKDS 60 
MOUSE           MARASCAWHSLWLLQWTPLFLGPSAVPPVWALNLDSEKFSVYAGPNGSHFGFSVDFHKDK 60 
ZEBRA FISH      ----MDKKLEFSLLFLSILIFT----NHIRGFNLDLNQYTVFSGPEDSYFGFSVDFYQSS 52 
XENOPUS         ------------MVPWLLLLLP----AFIQNLNLDK-KPQTLSGPPGSHFGFSMDFYNTA 43 
 
PIG             HGSVSIVVGAPRTLG--RNLEETGGVFLCPWKAKSVQCVALSFNLD-DETRNVGAQTFQT 117 
HUMAN           HGRVAIVVGAPRTLG--PSQEETGGVFLCPWRAEGGQCPSLLFDLR-DETRNVGSQTLQT 117 
HORSE           RGSVSIVVGAPRTLG--RSQEEMGGAFLCPWKAEGGQCTSLSFDLN-DETRNTSSQIFQT 117 
RABBIT          HGSVAIVVGAPRTLG--LGQKETGGVFLCPWKAEGSPCSLLSFNLS-DEYRKTSSQLFQT 117 
PERRO           HGRVAFVVGAPRTLG--RSQEETGGVFLCPWRAEGGQCTSLPFDLN-DETRHIGSHTFQT 117 
COW             NGSVYVVVGAPRTLG--HSEEETGGVFLCPWKAEGGQCISLPFDLY-DETRSIGTQTFQT 090 
RAT             HGSVSIVVGAPRALN--ANQEETGGVFLCPWKANNGTCTSLLFDLR-DETRKLSFQTFQT 117 
MOUSE           HGSVSIVVGAPRALN--ASQEETGAVFLCPWKANGGKCNPLLFDLR-DETRNLGFQIFQT 117 
ZEBRA FISH      SKSVSVVVGAPRANTNQSGVSHGGSVFMCPWATRGQSCQTLNFDQKGDENITFGNMLLMA 112 
XENOPUS         DQGMSIVVGAPRMQTSQRNVTMGGGVFLCPWKPKGSSCVNIKFDSTGDRSIPFAGYTMKI 103 
 
PIG             FKARQGLGASVLTWRDNVVACAPWQHWNVLEKNEE-AEKTPVGGCFVAQLQNSGRAEFSP 176 
HUMAN           FKARQGLGASVVSWSDVIVACAPWQHWNVLEKTEE-AEKTPVGSCFLAQPESGRRAEYSP 176 
HORSE           FKAQQGLGASVVSWSDYVVACAPWQHWNALEKTDE-AEKTPVGGCFVAQLENGRRAEYSP 176 
RABBIT          FRARQGLGASVVSWNDIIVACAPWQQWNVLEKAAE-AEKTPVGGCFVAHLPSGRRAEYSP 176 
DOG             FKSRQGLGASVVSWNDNIVACAPWQHWNVLEKTEE-AEKTPVGGCFVAQLRNGHRAEYSP 176 
COW             FKAGQGLGASVVSWRDSIVACAPWQHWNVLDRNEEEAQKTPVGGCFVAHLQNGDRTEYSP 150 
RAT             FKTGQGLGASVLSWNDVIVACAPWQHWNVLEKYDE-AEKTPVGGCFVAELQSGGRAEYSP 176 
MOUSE           FKTGQGLGASVVSWNDVIVACAPWQHWNVLEKRDE-AEKTPVGGCFLAQLQSGGRAEYSP 176 
ZEBRA FISH      HKSNQWLGASVRTYNNYILACAPLFHWNVLVDQEE-AMNTPVGNCQLLNMKTGELANYAP 171 
XENOPUS         FKSNQWFGATVRTWNTAIVACAPFQQWNVMKLGSE-SGTTPTGTCYITNN-LEDIYEFAP 161 
 
PIG             CRANLLSLVYVESKFND-RRYCEVGFSSAVTQAGELVLGAPGGYYFLSLMARAPIADIIS 235 
HUMAN           CRGNTLSRIYVENDFSWDKRYCEAGFSSVVTQAGELVLGAPGGYYFLGLLAQAPVADIFS 236 
HORSE           CRDNIMSHVYSKTYLGD-KRYCEAGFSSAVTQAGELVLGAPGGYYFLGLLARAPIANIVS 235 
RABBIT          CRGNTMSHVYEKMYLRD-LRSCEAGFSSVITQEGELVLGAPGGYYYLGFLVRAPIANIIS 235 
DOG             CRANTMSSVYVKNRFNQDKRYCEAGFSAAVTQAGVLVLGAPGGYFFLGLLVRTPIDNIIS 236 
COW             CRDNKMSQFYERNHFRDDRRYCEAGFSSVVTXAGELVLGAPGGYYFVSLLARAPIADIIS 210 
RAT             CRSNTMSSVYSQGFSGD-KRYCEAGFSLAVTQAGELVLGAPGGYFFLGLLVRVPIENIIS 235 
MOUSE           CRANTMSSVYAESFRGD-KRYCEAGFSLAVTQAGELVLGAPGGYFFLGLLARVPIENIIS 235 
ZEBRA FISH      CREEYVYAIYTRG--YPDRRYCEAGFTTDITKNGRVVLGAPGGYYFQGQIITASLVNIMS 229 
XENOPUS         CRESKMERHYEA-----DRRFCELGFSTDINKDGTLLAGAPWG-YFQGLYVTAGLPNILA 215 
 
PIG             SYRPGTLLWHVPTQKLTFDSDLPEYYESYLGYSVAVGEFDRNPNTTEYILGGPTWSMTLG 295 
HUMAN           SYRPGILLWHVSSQSLSFDSSNPEYFDGYWGYSVAVGEFDGDLNTTEYVVGAPTWSWTLG 296 
HORSE           SYRPGTLLWSVPTQRFTFDSMKPEYFDGYRGYSVAVGEFDEDLSTTEYVFGAPTWSWTLG 295 
RABBIT          SYSPGVLLWTVPNQNFTFDYSNRKYFDGYRGYSVAVGEFDGDLSTTEYVLGAPTWSWTMG 295 
DOG             SYRPGTLLWHVSSQSFTYDYSKPEYYDGYRGYSVAVGEFDGNLNTTEYVLGAPTWSCTLG 296 
COW             SYRPSTLLWHVPTQ-FTYDQSHLQYYDGYRGYSVAVGNFDGNPNTTEYVFGAPTWSWTLG 269 
RAT             TYRPGTLLWHVSNQRFSYDSSNPVYFHGYRGYSVAVGEFDGDLSTTEYIFGAPTWSWTLG 295 
MOUSE           TYRPGTLLWHVSNQRFTYDNSNPVFFDGYRGYSVSVGEFDGDPSTTEYVSGAPTWSWTLG 295 
ZEBRA FISH      SGSSFTPKHSMNGETKTPQRRD--YYDLYLGYSVAAGKFNND-NIPDYVVGVPNDLHTAG 286 
XENOPUS         RPASSSLLQSYPGQQISPYIGS--SFDSYKGFSVAYGEFTGD-NTPEIVVGSP-KYQDRG 271 
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PIG             AVEIFT---SKHQRLHLLQGEQVASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADHKL 352 
HUMAN           AVEILD---SYYQRLHRLRAEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKL 353 
HORSE           AVEILD---SNFQMLHRLHGEQMASYFGHSVAVTDVNGDRRHDLLVGAPLYMERRADRKL 352 
RABBIT          AVEILD---SYFYRLHRLQGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLFMASQADHKL 352 
DOG             AVEILN---EYHQTLHRLHGEQMASYFGHSIAVTDVNGDGRHDLLVGAPLFMESRADRKL 353 
COW             AVEILD---SYHQMLHRLHGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKL 326 
RAT             AVEILD---SYYQTLHRLHGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRVDRKL 352 
MOUSE           AVEILD---SYYQPLHRLHGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKL 352 
ZEBRA FISH      SVKIINGATVPLQIMKAISGTQIASYFGHSVAVTDINRDGWDDILIGAPLFMEQLSTQKF 346 
XENOPUS         LVDIYT-VSNPWKTFISFLGKQVASYFGHSVAVTDVNNDGRDDVLVGAPLFMERRTRGKL 330 
 
PIG             AEVGRVYLFLQSRGHHSLGTPSLLLTGTQLYGRFGSAIAPLGDLNRDGYNDVAVAAPYGG 412 
HUMAN           AEVGRVYLFLQPRGPHALGAPSLLLTGTQLYGRFGSAIAPLGDLDRDGYNDIAVAAPYGG 413 
HORSE           AEVGRVYLFLQPRSPQPLGPASLLLTGTRIYGRFGSAIAPLGDLNRDGYNDVAVAAPYGG 412 
RABBIT          AEVGRVYLFLQLQGPHLLGAPSLLLTGTQLYGRFGSAIAPLGDLNRDGYNDVAVAAPYGG 412 
DOG             AEVGRVYLFLQPRGHQALGAPSLLLTGTQLYGRFGSAIASLGDLDRDGYNDVAVAAPYGG 413 
COW             AEVGRVYLFLQTRGARMLGAPNLLLTGTQLYGRFGSAIAPLGDLNRDGYNDVAVAAPCGG 386 
RAT             AEVGRVYLFLQPKGLQALSSPTLVLTGTQVYGRFGSAIAPLGDLNRDGYNDVAVAAPYGG 412 
MOUSE           AEVGRVYLFLQPKGPQALSTPTLLLTGTQLYGRFGSAIAPLGDLNRDGYNDIAVAAPYGG 412 
ZEBRA FISH      REVGQVYVYLQRNDFSFASRPNQILAGTYAYGRFGSAIAPLGDLDHDGFNDVAVGAP--G 404 
XENOPUS         QEFGQVYVYLQRENRKFSFN-HPVLTGSQVYGRFGSSIAPLGDIDQDGFNDVAVGAPFGG 389 
 
PIG             PTGQGQVSVFLGQSEGLNSQPSQVLHSPFA---AGSAFGFSLRGATDIDDNGYPDLLVGA 469 
HUMAN           PSGRGQVLVFLGQSEGLRSRPSQVLDSPFP---TGSAFGFSLRGAVDIDDNGYPDLIVGA 470 
HORSE           PDGRGQVLVFLGQSEGLSSHPSQVLDSPFS---TGSAFGFSLRGATDIDDNGYPDLLVGA 469 
RABBIT          PSGRGQVLVYLGQSEGLNPHPSQVLDSPFP---AGSAFGFCLRGATDIDDNGYPDLLVGA 469 
DOG             PSSLGQVLVYLGQSEGLSSRPSQILDSPFP---AGSGFGFSLRGATDIDDNGYPDLLVGA 470 
COW             PNGQGQVLVYLGQSEGLNPSPSQVLDSPFP---TGSGFGFSLRGATDIDDNGYPDLLVGA 443 
RAT             PSGQGQVLIFLGQSEGLSPRPSQVLDSPFP---TGSGFGFSLRGSVDIDDNGYPDLIVGA 469 
MOUSE           PSGQGQVLIFLGQSEGLSPRPSQVLDSPFP---TGSGFGFSLRGAVDIDDNGYPDLIVGA 469 
ZEBRA FISH      SVDGGKVFIYLGKSGGLSTQYVQVIESPFRSLIDPPMFGFSIRGGTDIDDNGYPDLIIGA 464 
XENOPUS         ESGGGCVFIYRGSPAGLSPQPSQILESPLP---PPAQFGFALRGGMDIDNNGYPDLLVGA 446 
 
PIG             YGADKVVVYRAQPVVTATVQLMVQ-ESLNPAVKNCVQPQTKTPVSCFTIQMCVGATGHNI 528 
HUMAN           YGANQVAVYRAQPVVKASVQLLVQ-DSLNPAVKSCVLPQTKTPVSCFNIQMCVGATGHNI 529 
HORSE           YGANKVAVYRAQPVVMVSVQLLVN-DSLNPAVKNCVLPQKKTSVSCFDIQMCVGVTGHNI 528 
RABBIT          YGADKVVVYRAQPVVMADVQLLVQ-DSLNPAVKNCVLHQTNTPVSCFNIQMCVGVTGHNI 528 
DOG             YGASKVAVYRAQPVVVANVQLLVQ-DSLNPAVKNCILPQTKTPVSCFNIQMCVGATGHNI 529 
COW             YGASKVVVYRAQPVVMVTVQLMVQ-DSLNPAVKTCVLSQTKTPVSCFNIQMCVGATGHNI 502 
RAT             YGASKVAVYRAQPVVMATVQLMVQ-DSLNPTLKNCVLEQTKTPVSCFNVQMCVGATGHNI 528 
MOUSE           YWASKVAVYRAQPGVMATVQLMVQ-DSLNPTLKNCVLDQTKTPVSCFNIQMCVGATGHNI 528 
ZEBRA FISH      WGASKVVTYRAQAVVRTQARLSFFPDLLNPEDKFCQLQQSGTYITCFTIMACIRVSGHRI 524 
XENOPUS         FHADKVFIFRTQPVVVLQASLFFNPEALNPDEKLCNFPQSGPAVSCFTIRVCAQASGRSL 506 
 
PIG             PEKLRLNAELQLDRQKPHQSRRVLLLASQQASTVLDVDLTWRQSPTCHNTTAFLRDEADF 588 
HUMAN           PQKLSLNAELQLDRQKPRQGRRVLLLGSQQAGTTLNLDLGGKHSPICHTTMAFLRDEADF 589 
HORSE           PEKLRLNAELQLDRQKPRQGRRVLLLSSQQAGTTLHLDLGGRTSPNCRTIEAFLRDEADF 588 
RABBIT          PQGLYLQAELQLDRQKPRQGRRVLLLGSQQASTTLSMDLGGRQSRLCHNTTAFLRDEADF 588 
DOG             PQQLSLNAELQLDRQKPRQGRRVLLLNSQLASSTLHLDLGGRHSPICHTTTAFLRDEADF 589 
COW             PEKLHLNAELQLDRQKPRQGRRVLLLDSQQAGTILNLDLRGRHNPNCSTATAFLRDEADF 562 
RAT             PQKLHLKAELQLDLQKPRQARRVLLLASRQASLTLSLDLGGRNKPICHTIKAFLRDEADF 588 
MOUSE           PQKLHLKAELQLDLQKPRQGRRVLLLASQQASLTLSLDLGGRDKPICHTTGAFLRDEADF 588 
ZEBRA FISH      PQQIVFNTELQLDRMKQSMARRTLLLDSNQPYTNFQISVDRNSRDVCRNFTAYLLP--EF 582 
XENOPUS         PKKISLSAELQLDRLKSRFARRTFFLDSSQPSKTIDMELQSNSAQLCQNLTPYLRGESEF 566 
 
PIG             RDKLSPIVLSFNVSLQPEKNGDALTFMLHGDTHVQEQTRIILDCGEDQVCVPKLQLSANT 648 
HUMAN           RDKLSPIVLSLNVSLPPTEAGMAPAVVLHGDTHVQEQTRIVLDSGEDDVCVPQLQLTASV 649 
HORSE           RDKLSPIVLSLNVSLQPEKDGIAPALVLHGDTHVQEQTRIILDCGEDDLCVPQLHLTANV 648 
RABBIT          RDKLSPIVLSFNVSLQPKEAGVAPAVVLHGNTHVQEQTRIILECGEDDVCVPQLHLTASL 648 
DOG             RDKLSPIVLSLNVSLQPRKDGVAPAIVLHGDTHVQEQTRIILDCGEDDLCVPQLQLTAIV 649 
COW             RDKLSPIVLSFSVSLPPEKDGGAPALVLHGNTHVQEQ----------------------- 599 
RAT             RDKLSPIVLSLNVSLPPEETGVAPAVVLHGVTHVQEQTRIILDCGEDNLCVPQLQLTATA 648 
MOUSE           RDKLSPIVLSLNVSLPPEETGGAPAVVLHGETHVQEQTRIILDCGEDDLCVPQLRLTATA 648 
ZEBRA FISH      KDKLSPIFISVNYSLADSQ-----NAVLHGQSVAVGQTRIILNCGPDNVCIPDLQLKAVT 637 
XENOPUS         KDKLSPIAMSVNFSLVRAQSMDTVQPTLHGTTFLQEQTNILLDCGDDNVCIPNLHLTANW 626 
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PIG             TGSPLLVGADNVLELHVVAANEGEGAHEAELVVHLPPGAHYMQALSNTKSFERLICTQKK 708 
HUMAN           TGSPLLVGADNVLELQMDAANEGEGAYEAELAVHLPQGAHYMRALSNVEGFERLICNQKK 709 
HORSE           TGSPLLIGADNVLKLQMDATNEGEGAYEAELAVQLPPGAHYMQALSNIEGFERLICDQKK 708 
RABBIT          KGSPLLIGADNVLELQMVAANDGEGAYEAELVVHLPLGAHYMRAVSTMEGLERLICNQRK 708 
DOG             MGSPLLIGADNVLELQMDAANEGEGAYEAELAVHLPPGAHYMRAISNIEGFERLICNQKK 709 
COW             -------------------------------------------------GFERLICNQKK 610 
RAT             GDSPLLIGADNVLELKVNASNDGEGAYEAELAVHLPPGAHYIRAFSNVKGFERLVCTQKK 708 
MOUSE           GDSPLLIGADNVLELKIEAANDGEGAYEAELAVHLPPGAHYMRALSNIEGFERLVCTQKK 708 
ZEBRA FISH      STEPILIGDENPALLIIEAENQGEGAYETELYISPPANTHYQGVLSNHEDFSALVCGQKK 697 
XENOPUS         SADPLLIGIDNLVHVQFNAANLGEGAYEAELYVWLPNGAHYMQVLG--EAEEKILCSPKK 684 
 
PIG             ENETKVVLCELGNPMKGDTQIEITMLVSVGNLEEAGEHVSFRLQIRSKNSQNPNSETVVL 768 
HUMAN           ENETRVVLCELGNPMKKNAQIGIAMLVSVGNLEEAGESVSFQLQIRSKNSQNPNSKIVLL 769 
HORSE           ENETKVVLCELGNPMKRNAQIEITMLVSVENLEEAGETVSLQLQIRSKNSKNPNSETLRL 768 
RABBIT          ENQTKAVLCELGNPMK-QARIGITMLVSVGNLEDAGESVSFQLQIRSKNSQNPNSEAVLL 767 
DOG             ENETKIVLCELGNPMKRNARIGITMLVSVENLEEAGEHVSFWLQIRSKNSQNPNSEAVLL 769 
COW             ENETKVVLCELGNPMKSNAQIEVMMWVSVEKLEEAGEQVSFLLQIRSKNSQNPNSEMVEL 670 
RAT             ENESRLALCELGNPMKKDTRIGITMLVSVEILEEAGDSVSFQLQIRSKNSQNPNSEAVLL 768 
MOUSE           ENESRVALCELGNPMKKDTRIGITMLVSVENLEEAGESVSFQLQVRSKNSQNPNSKVVML 768 
ZEBRA FISH      ENGSVIVVCDLGNPLEAGQQLKAGLYFSMGDLEQVENHITFQMQIRSKNSQNSDSNLVQL 757 
XENOPUS         GNESEIVVCELGNPMKNGAEIHADLQLSFSNLEDSGSTVTFQMQIKSRNTVNSASSLFLV 744 
 
PIG             DVQVRAEAHLELRGNSFPASLLMAA-EGDWE---NSSDNLGPKVEHTYELHNNGPSTVSG 824 
HUMAN           DVPVRAEAQVELRGNSFPASLVVAAEEGEREQ--NSLDSWGPKVEHTYELHNNGPGTVNG 827 
HORSE           HVPVRAEARVELRGNSLPASLVVAAEEDDRK---NSSDSWGPKVEHTYELHNNGPGAVRG 825 
RABBIT          AVPVRAAAQVELRGNSFPASLVLAEEGDQEQ------NSLDLKVEHTYELHNNGPGTVRG 821 
DOG             DVPVRAEAHVKLRGNSFPASLVVVAEEDNRE---NSSESWGPKVEHTYELHNNGPGTVSG 826 
COW             DVPVRAVAHVELRGNSFPASLVVAAEEGNGQ---NSSDSWGPKVEHTYELHNNGPGAVSG 727 
RAT             PVAVRAEAAVELRGNSFPASLVVAAEEVDKEQ--DGLDSWVSRVEHTYELHNNGPGTVNG 826 
MOUSE           PVAIQAEATVELRGNSFPASLVVAAEEGDREQ--EDLDSWVSRLEHTYELHNIGPGTVNG 826 
ZEBRA FISH      QVNVTAVASLEMRGVSSPVDCVLPISKWESKDYPEDLDEVGPLIEHVYELRNRGPSPVN- 816 
XENOPUS         TMAVKVTASLELRGSSHPAEVILPLPNWEPREEWRKAQDYGEEVTHVYELHNSGPGSVH- 803 
 
PIG             LHLRLHLPTGQSQTSDLLYIVDIQTQGGLQCSPQPSPNPRQLDWG--LHSPTPSPVYPAH 882 
HUMAN           LHLSIHLPG-QSQPSDLLYILDIQPQGGLQCFPQPPVNPLKVDWG--LPIPSPSPIHPAH 884 
HORSE           LRLSLHLPS-QSQPSDLLYILDIQPQGGLQCSPQPSPNPLKLDWG--LPTPSPSPVYHPR 882 
RABBIT          LHLTIHLPG-QSQPSDLLYILGIEPQGGLQCSPQPSPNPLKINWR--LPTPSPSPMHPGY 878 
DOG             LHLHLCFPG-ESQPSDLLYILDIQPEGGLQCSPQPSINPFKLDWR--QPTPSPSPTSPGY 883 
COW             LRLNLYLPS-QSQPSDLLYILDIHPQGGLQCASQPSPNPLQLEWR--LPTPSPS---PAH 781 
RAT             LSLIIHLPG-QSQPSDLLYILDVQPKGGLLCSTQPPPKLLKVDRS--LTTPSPSSIRRIH 883 
MOUSE           LRLLIHIPG-QSQPSDLLYILDVQPQGGLLCSTQPSP---KVDWK--LSTPSPSSIRPVH 880 
ZEBRA FISH      VKLTLEFPV-SQNESYLLYVFANASEELISCQTDYAN----IDPRRLVKQESTNITVAEV 871 
XENOPUS         VQLLLQSPE-MYHGDYFLYPLRLEVDDGMTCDNQSALNPLKLDILTSTEEPANYSSRSGD 862 
 
PIG             HKRNRRQAVL--------------PGQKQPLSLQDPILLSCD-SAPCTVVHCDLPEMARG 927 
HUMAN           HKRDRRQIFL--------------PEPEQPSRLQDPVLVSCD-SAPCTVVQCDLQEMARG 929 
HORSE           HQRERREAFL--------------PGPMQPSRLQDPVLVNCD-SAPCTVVQCELEEMARG 927 
RABBIT          RRERRHADLLE-------------PQPSSAAGPRDPVLVSCD-SAPCTVVQCELQEMARG 924 
DOG             HKRERRQASL--------------PGSSQPSGLQDPVLLSCK-SGPHTVVQCELQEMARG 928 
COW             HKRDRRQAVL--------------PEEKQPSRLQDPILVSCD-SAPCTVVQCELQEMARG 826 
RAT             HDRDRREASP---------------QGSKQTEQQDPVLVSCNGSAPCTVVECELQEMVRG 928 
MOUSE           HQRERRQAFL---------------QGPK-PGQQDPVLVSCDGSASCTVVECELREMVRG 924 
ZEBRA FISH      HHFNKRDLS---------------QKTENEQQWQHTVHVNCSSSEQCVVFDCVAAGLQRD 916 
XENOPUS         HRLERRDLRRWGADEGMQEDGVNITKKDEKPPRNHTVLLNCSSFP-CWEVQCSVQNLERG 921 
 
PIG             QRAMVTAQAFLWLPSLRQRPLDQFVLRSHAWFNVSSLPYAVPALSLPSGEAQVQTQVLRV 987 
HUMAN           QRAMVTVLAFLWLPSLYQRPLDQFVLQSHAWFNVSSLPYAVPPLSLPRGEAQVWTQLLRA 989 
HORSE           QRAMVTVRAFVWLPSLRQKLLDQFVLQSRAWFNVSSLPYAVPTLSLPSGEALVQTQLLRV 987 
RABBIT          QRAMVTVLALLGLSSLRERPLDQFVLQSQAWFNVSSLPYAVPALSLPSGEALVQTQLLRV 984 
DOG             QRAMVKVLAFLQLPSLQQRPLDQFVLESQAWFNVSSLPYAVPSLSLPSGETLVQTHLLRA 988 
COW             QRVMVTVLALLSRSILQERPLDQFVLQSHAWFNVSSFPYSVPALSLPSGEALVQTQLLRV 886 
RAT             QRAMVTVQATLGLSILRQRPQEQFVLQSHAWFNVSSLPYSVPVVSLPSGKALVQTHLLRA 988 
MOUSE           QRAMVTVQAMLGLSSLRQRPQEQFVLQSHAWFNVSSLPYSVPVVSLPSGQARVQTQLLRA 984 
ZEBRA FISH      ERAIVRVMSRLWVQTFLKRPYVNYVLHSTAHYEVMNVPSKIQPDVLPTGKAETHTKIIWR 976 
XENOPUS         GRATVKLHSILWVPSFLKRQQQQFVLLSQGSFWVTSVPYKIQPAVLLYGNATANTTVLWV 981 
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PIG             RVLEDREVPLWWMLVGVLGGLLLLTLLVLAMWKCGFFKRNRPPLEESDEEEE------- 1039 
HUMAN           L--EERAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNRPPLEEDDEEGE------- 1039 
HORSE           L--EDRAIPIWWVLVGVLGGLLLLTLLVVAMWKVGFFKRNRPPLEEDEEDE-------- 1036 
RABBIT          L--EEKAVPIWWVLVGALGGLLLLILLVLAMWKVGFFKRNRLPLEEEDEDEE------- 1034 
DOG             L--EERDIPIWWVLVGVLGGLLLLMLLVLAMWKGGFFKRNRPPLEEEEEE--------- 1036 
COW             S--EEREIPMWWVLVGVLGGLLLLTFLILAMWKVGFFKRNRPPLEEDDEEE---------0935 
RAT             L--EERDIPVWWVLVGVLGGLLLLTLLVLAMWKAGFFKRNRPPLEEEEEEE-------- 1037 
MOUSE           L--EERAIPVWWVLVGVLGGLLLLTLLVLAMWKAGFFKRNRPPLEEDEEEE-------- 1033 
ZEBRA FISH      SPDGQEEVPLWWIVVSIVAGLLLLAALSTIFWKMGFFKRNRPPSDNDDDDDDDVTQQLN 1036 
XENOPUS         SPDGQKEIPLWWIIVGALGGLLLLALFVFVMWKLGFFRRTRPPSDDQEDLTSD------ 1034 
Fig. 5. Comparison of the porcine CD41 amino acid sequence to other homologous 
molecules. The sequences were derived from GenBank entries with accession numbers 
shown in materials and methods. Signal peptide is in green. Heavy and light chains are 
shown by orange and black lines, respectively. Ca++ binding domains are remarked in pink 
boxes. Potential N-glycosylation sites (N) and cysteine residues (C) are respectively marked 
in red and yellow in the respective sequences. Amino acids residues conserved in all the 
sequences are shown in light grey. 
As shown in Table2, the longest porcine CD41 protein shares a 78% amino acid residue 
identity with those of humans, cattle and horses, 77% with dogs, 75% with rabbits, 73% with 
rats, 71% with mice, 42% with Xenopus laevis and 40% with zebrafish. Table2 also shows the 
percentages of amino acid residue identities of the different regions of the CD41 molecule. 
In general, both transmembrane and cytoplasmic domains are more preserved compared to 
the extracellular one. The phylogenetic tree of CD41 proteins shows that the counterpart 
closet to porcine CD41 was that of cows (Figure6).  
 
 
 
 
 
 
Table 2. Percentages of amino acids identities between the porcine (Po) and its constitutive 
blocks with those from humans (Hu), cow (Ca), horse (Ho), dog (Do), rat (Ra), mice (Mi), 
rabbit (Rb), zebrafish (Zf) and Xenopus laevis (Xe). 
E SPE CI ES PR OT EI N EX TR A C EL  
L UL A R  
T AR N SM EM
B RA N E 
C YT OPL AS 
M IC  
H U MA N 7 8 77  8 0 8 5 
C OW  78  77  8 0 8 9 
H OR SE 78  77  8 0 7 8 
D OG 77  77  8 0 8 3 
R AT  7 1 71  8 4 8 4 
M OU SE 7 3 72  8 4 8 4 
R AB BIT  7 5 74  8 0 8 0 
Z EB RA  F IS H 4 0 41  5 3 5 5 
XE NO PU S 4 2 42  6 9 4 0 
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Fig. 6. Phylogenetic tree of the CD41 protein family. 
3.3 Chromosome localization of porcine CD41 gene 
Chromosomal localization was carried out screening a pig-rodent somatic hybrid cell panel 
by PCR, using specific porcine CD41 primers (Table1). A specific amplification was 
observed in 9 (16, 20, 21, 22, 23, 24, 25, 26 and 27) of the 27 hybrid cells (Figure7), which 
enabled us to localize the porcine CD41 gene in region p11-2/3p13 of chromosome 12 (Sscr 
12) with a probability of 0.90 and an error margin lower than 0.1% (Chevalet et al., 1997, 
www.toulouse.inra.fr/lqc/pcr.htm). 
The chromosome localization of the gene was confirmed by screening the INRA Minnesota 
porcine Radiation Hybrid (IMpRH) panel. The IMpRH mapping tool (Milan et al., 2000; 
www.imprh.toulouse.inra.fr) revealed that porcine CD41 gene is closely linked to the SW957 
marker (47cM; LOD=9) on the Sscr 12, p11-p13 region (Figure8).   
 
 
 
 
 
 
 
 
Fig. 7. Diagram showing results for the presence/absence of the CD41 gene in the INRA 
somatic hybrid cell panel. 
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Fig. 8. Diagram showing the chromosomal localization of the CD41 gene using the INRA 
Minnesota porcine Radiation Hybrid (IMpRH) panel. 
3.4 Cell and tissue expression of porcine CD41 transcripts 
To investigate the pattern of the porcine CD41 mRNA expression, RT-PCR analysis was 
conducted with a variety of pig adult tissues and cell types using VARP1/VARP2 gene-
specific primers (Table1). The highest level of CD41 transcripts was detected in platelets, 
although a moderate level was detected in bone marrow and a low level in ganglions and 
lungs. No CD41 transcripts were detected in the rest of tissues and cells analyzed (Figure9).  
 
 
Fig. 9. RT-PCR expression patterns of CD51 transcripts in different pig cells and tissues. RU: 
Relative units. 18S RNA amplification was used as control. 
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3.5 Cell and tissue expression of porcine CD41 proteins 
The precise localization of the CD41 protein was studied by immunohistochemistry and by 
flow cytometry with antibodies developed against two different porcine CD41 recombinant 
proteins. 
3.5.1 Expression and purification of porcine recombinant CD41 proteins  
Two different cDNA fragments belonging to the functional region of the porcine CD41 
protein were amplified and subcloned in the pET-28b expression vector. One, 996 bp long 
and amplified with primers CD41-F2 and CD41-R2 (Table1), contained the coding 
sequence for amino acids 32 to 363, and the other one, 677 bp long and amplified with 
primers CD41-F1 and CD41-R1, contained the coding sequence for amino acids 684 to 
909, a highly antigenic region selected by the Jameson-Wolf method (Jameson & Wolf, 
1988).  The recombinant constructions, named respectively pET-F2R2 and pET-F1R1, 
were transfected and expressed in E. coli (DE3). Two different recombinant CD41 
proteins were purified: rCD41-F1R1 (about 26 kDa) and rCD41-F2R2 (about 46 kDa) 
(Figure10).  
 
 
Fig. 10. Purified CD51 recombinant proteins. A: rCD41-F1R1. B: rCD4-F2R2. 
3.5.2 Production of antibodies against porcine rCD41 proteins  
An anti-rCD41-F2R2 monoclonal antibody (GE2B6), and two anti-rCD41-F2R2 and anti-
rCD41-F1R1 polyclonal antibodies were produced, and their specific reactivity against the 
rCD41 proteins tested in immunoblottings.  Before being used in immunohistochemical 
assays, their ability to specifically recognize the platelet CD41 molecules were carried out 
through immuno precipitations of platelets lysates in non-reduced conditions. An anti-
porcine CD61 (JM2E5), previously produced by us (Pérez de la Lastra et al., 1997), was 
used as a positive control. Results are shown in Figure11 in which both polyclonal 
antibodies, the same as JM2E5, identified two proteins of 110 and 90 kDa, corresponding 
to the α and β chains of the receptor αIIbβ3. The antibodies αIIb specific recognition was 
demonstrated through an immunoblotting of platelet lysates in non-reducing conditions 
(Figure12).  
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Fig. 11. Immunoprecipitation results of platelet lysates with anti-rCD41-F1R1 and anti-
rCD4-F2R2 in non reducing conditions. JM2E5 anti-CD61 antibody was used as a control 
(C+).  
 
 
 
 
 
 
Fig. 12. Immunoblotting results of anti-rCD41-F2R2 and JM2E5 against a porcine platelet 
lysate.   
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3.5.3 Immunohistochemical detection of CD41 proteins 
The reactivity of the anti-CD41 monoclonal and polyclonal antibodies was tested by 
immnohistochemestry on a variety of porcine tissues and cells types. Results are shown in 
Figures 13 and 14. Immunoreactivity was only detected in the membranes of 
megakaryocytes from bone marrow. No reactivity was detected in any of the tissues 
checked, including ganglion, in which a weak CD51 transcription was detected by RT-
PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. Immunohistochemistry results with anti-rCD41-F2R2. A: Bone marrow (40X), MK, 
megakaryocyte.  B: Aorta (20X). C: Small intestine (10X). D: Large intestine (10X). E: Uterus 
(10X).    
M
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Fig. 14. Immunohistochemistry results with anti-rCD41-F2R2. A: Spleen (2X).  B: Ganglyon 
(20X). C: Kidney (10X). D: Thymus (10X). E: Tonsil (10X). 
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3.5.4 Detection of CD41 proteins by flow cytometry 
In order to identify the possible PBL cells that express CD41 proteins we carried out a flow 
cytometry analysis by using both anti-CD41 polyclonal antibodies. Figure15 shows the 
results in platelets, lymphocytes, granulocytes and erythrocytes with anti-CD41-F2R2. CD41 
proteins were only detected in platelets by both polyclonal antibodies.  
Furthermore, to test the platelet porcine specificity of the antibodies produced in this study 
we test their reactivity with platelets from pigs, humans, dogs, horses, goats, chats, sheep 
and cows by flow cytometry. Both anti-CD41-F2R2 and anti-CD41-F1R1only reacted with 
porcine platelets (Figure 16), confirming the porcine CD41 specificity of both antibodies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15. Flow cytometry with anti-rCD41-F2R2 detecting expression in blood cells. 
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Fig. 16. Flow cytometry with anti-rCD41-F2R2 showing no CD41 expression in platelets 
from different mammals. 
3.6 Effect of the platelet activation on the expression of porcine CD41 
Previous results obtained in our lab using a two dimension differential in gel electrophoresis 
(2D-DIGE) technique had shown that the proteome of thrombin activated porcine platelets 
showed a reduced number of proteins affected in their expression level, among which CD41 
was not found. Although CD41 is strongly expressed in platelets, the membrane proteins are 
usually poorly represented in the gels as a consequence of their high hydrophobicity.  As we 
had produced specific anti-CD41 polyclonal antibodies, we used the anti-rCD41-F2R2 to 
check, using immunoblotting, if CD41 was or not present in a similar gel than that used in 
our previous study. Results are shown in Figure 17 in which CD41 integrin was clearly 
detected.  
In order to test if the CD41 transcripts level was or not modified in the platelets after 
activation by thrombin, we carried out a real time quantitative PCR (rt-q-PCR) with RNAs 
from unstimulated and stimulated platelets. Results are shown in Figure18 in which a 
higher but not significant change in the CD41 transcripts level was detected after the 
activation by thrombin (the significant value is 1.5). Three replicates were assayed with very 
similar results. 
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Fig. 17. A: Two dimension gel electrophoresis showing the platelet proteome stained with 
Comassie blue. B:  Immunoblotting of platelet proteome with anti-rCD41-F2R2. Red circle 
shows detection of CD41 protein. 
 
 
Fig. 18. Real time quantification of CD51 transcripts in unstimulated and thrombin 
stimulated platelets. R: Ratio (relative abundance to β-actin mRNA). Results represent the 
average of three replicates. 
4. Discussion 
In general, the study of genes expressed in platelets is difficult since platelets are enucleated 
cells that show a reduced level of protein synthesis, and megakaryocytes, the platelets 
precursors, represent only 0.1% of bone marrow cells (Bray et al., 1987). Nevertheless, in the 
present study we describe for first time the cloning and characterization of the full-length 
cDNA for the porcine CD41 (αIIb) integrin chain.  
The porcine CD41 proteins share common structural elements, including cytoplasmic, 
transmembrane and extracellular domains and the position of the proteolytic cleavage sites 
with the CD41 protein of other species. The porcine CD41 integrin showed an average of 
75% amino acid identity with their mammal orthologous molecules, being the conservation 
in the transmembrane and cytoplasmic regions higher than in the extracellular one in all the 
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species compared. The phylogenetic tree of CD41 family of proteins showed that the closest 
to porcine CD41 were those of cows and horses, and that the clusters of domestic mammals 
showed the less divergence in evolution. However, compared with other α  mammal 
integrins, like αv which show 90% of identity (Yubero et al., 2011), αIIb integrins show lower 
level of conservation, which could be associated with the number of β chains with which 
they can form receptors: only one (β3) for αIIb, and at least five for αv. 
Porcine CD41 conserves all the main structural characteristics that define their functions in 
other species. The extracellular domain shows that porcine CD41 belongs to α integrins 
lacking I domain, a domain present in the NH2 extreme of some integrins, like α1, α2 or β2, 
which contains the functional sites to bind to ligands (Dickeson & Santoro, 1998; 
Humphries, 2000). Porcine and human αIIb, the same as αv, α5 and α8 ones, spreads the ligand 
binding sites among the first 334 NH2 amino acid residues (Loftus et al., 1996).  One 
characteristic of the α integrins lacking I domain is the presence of the seven FG-GAP 
tandem repeat sequences (W1 to W7; see Figures 3 and 4). Each FG-GAP sequence 
determines four antiparallel β chains, and the folding of all the seven FG-GAP sequences 
establishes the globular structure of the integrin, which contains the ligand binding sites. 
Fibrinogen is the main ligand for αIIbβ3 complex. In humans, the binding of fibrinogen to 
αIIbβ3 receptor requires the αIIb chain Ala294 to Met314 residues, which are located in the third 
FG-GAP repeat (D’Souza et al., 1990). Other experiments, including molecular 
characterization of the Glanzmann thrombasthenia and mutagenesis analysis, have shown 
that residues Ala145, Asp163, Leu183, Glu184, Tyr189, Tyr190, Phe191 and Asp224 of the αIIb chain, 
are also critics for the fibrinogen binding (Grimaldi et al., 1998; Honda et al., 1998; Tozer et 
al., 1999). The comparison between human and porcine αIIb integrin sequences showed that 
all these critic residues are conserved in the porcine molecule. 
On the other hand, the fibrinogen only binds to the activated αIIbβ3 integrins, this activation 
being mediated by Ca++ (Bennett & Vilaire, 1979). The molecular characterization of αIIb 
carried out in this study showed that all the four Ca++ binding domains (consensus sequence 
DX[D/N]XDGXXD) were also highly conserved in the porcine αIIb integrin when compared 
to that in humans. 
The transmembrane region of the porcine αIIb integrin is also highly conserved when 
compared to their homologous mammalian (80-84% of identity). The sequence GXXXG in 
this region is essential for a high affinity association of the transmembrane helixes (Senes 
et al., 2000). Changes as AXXXG or SXXXG in this sequence reduce significantly the 
affinity between them (Mendrola et al., 2002; Schneider & Engelman, 2004). Our results 
showed that the same GVLGG sequence was conserved in the αIIb integrins from all the 
mammalian species compared, including that of the pig. It has been suggested and 
supported a “push-pull” mechanism for αIIbβ3 regulation in which the destabilization of 
the  hetrodimeric αΙΙb and β3 transmembrane interactions push αIIbβ3 to its activated state, 
whereas processes that favor their homomeric association pull αIIbβ3 toward its active 
conformation (Li et al., 2005; Yin et al., 2006). This is in concordance with the high 
conservation of the GVLGG sequence in the transmembrane region of the porcine (and 
other mammal) αΙIb chains, since fibrinogen binding to αIIbβ3 is a prerequisite for platelets 
aggregation (Bennett, 2005). It is worthy to note that the porcine αv integrin, also present 
in platelets membranes, contains an AVLGG sequence in the transmembrane region, as 
well as in all their mammalian homologous with which it was compared (Yubero et al, 
2011). 
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The cytoplasmic region of the porcine αIIb integrin is also highly conserved (80-89% of 
identity when compared to their homologous mammalians). A short GFFKR motif, which 
was involved in the activation of the integrin receptors, is present in the cytoplasmic region 
of all the human α integrins. In humans, mutations in the GFFKR motif of the αIIbβ2 integrin 
receptor induce a permanent activation of the integrins. As expected, in all the species 
compared in this study, the porcine αIIb integrin contains this motif near to the 
transmembrane region. The porcine αIIb integrin also contains in the cytoplasmic region the 
PPLEE motif, present in all the mammalian αIIb integrin compared in this study, whose 
modifications determine changes that interfere with the specific recognizing of the ligands 
(Filardo & Cheresh, 1994). 
Once the porcine αIIb integrin was characterized, we used a porcine radiation hybrid panel 
and a somatic cell hybrid panel to map the pig CD41 (αIIb) gene into swine chromosome 12 
(Sscr 12), region p11(2/3)-p13. This chromosomal localization is in total concordance with 
heterologous painting data that demonstrate the correspondence between the swine Sscr 12 
and the human Hsap 17 chromosomes (Rettenberger et al., 1995), where CD41 (αIIb) gene 
maps in the human Hsap 17 q21 region (Bray et al., 1987), homologous to the porcine Sscr 12 
p11-p13 one (Figure 19).  
 
 
Fig. 19. Chromosomal localization of porcine and human CD41 genes showing the 
correspondence between porcine Sscr 12 and human Hsap 17 chromosomes. 
It is interesting to note that the swine CD41 (αIIb) and CD61 (β3) genes are closely located -
which confirms our previous results (Morera et al., 2002)-, the same as in humans, where 
both genes map together in chromosome 17, q21 region (Thornton & Poncz, 1999).  This is 
exceptional for genes coding for α and β integrins belonging to the same receptor, and it 
must have a functional significance, as both genes are simultaneously expressed in human 
megakaryocytes (Bennett et al, 1983). Therefore, the chromosomal assignment of pig 
CD41(αIIb) gene provides additional evidence of the conserved linkage homology in these 
chromosome regions among pigs and humans.  
We also checked in this study the porcine αIIb expression profile in different cells and 
tissues. When we used RT-PCR to detect the αIIb transcripts level, we observed, as 
expected, a strong expression in platelets and in bone marrow. However, we also detected 
a lower expression in lymphatic ganglion and lung, which we explain by the probable 
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presence of platelets or blood cells in them. When we used immnunohistochemisty and 
flow cytometry to locate accurately the CD41 (αIIb) protein expression with specific 
antibodies produced by us, we confirmed that the presence of CD41 proteins was 
restricted to platelets and megakaryocytic membranes. The same restricted expression 
pattern of αIIb proteins have been detected in other species, like humans and mice, 
although some studies suggest that αIIb could be a differentiation marker expressed in 
early stages of the cellular hematopoietic differentiation (Mitjavila-García et al., 2002) or 
to be over expressed in tumor cells (Raso et al., 2004).  In fact, the αIIb/β3 integrin 
expression in tumor cells has been controversial as αΙΙβ and αv integrin have similar 
structures, and although the role of the CD51 integrin in tumor metastasis and 
angiogenesis is well documented (Chen, 1992, 1997; Mitjans et al., 2000), these studies 
have been carried out using antibodies that could cross react with the αv/β3 receptor (Chen 
et al., 1992; Chen 2006). However, some studies have revealed that the αΙΙβ/β2 receptor 
mediates interactions between platelets and tumor cells, detecting an over expression in 
the filopodia emitted by the platelets in the focal adhesion  plates, with the filopodia 
being the first contact sites between tumor cells and platelets (Chopra et al., 1992). 
In this sense, it is worthy to note that in our study we have produced the two first specific 
anti-porcine αIIb antibodies, whose specificities we have demonstrated by flow cytometry in 
cross reactions against platelets from humans, dogs, horses, goats, cats, sheep and cows.  
Finally, as αIIb/β3 is involved in adhesion and aggregation of platelets after their activation, 
we checked if the platelet activation was or not associated with changes in the 
αIIb transcripts level. Changes in the proteome of platelet activated by thrombin, the 
strongest platelet activator, was previously studied in our  laboratory, detecting some 
differential modification in only a small number of proteins, among which the CD41integrin 
was not included, even though a very sensitive two dimension differential in gel 
electrophoresis (2D-DIGE) technique was used (Esteso et al., 2008). As CD41 is strongly 
represented in platelets and it plays an essential role in their activation, we took advantage 
of the specific anti-porcine αIIb antibodies produced for the studies presented in this chapter 
to check if CD41 integrin was or not present in the gels used to carry out those studies. 
Immunoblotting results clearly showed that CD41protein was detected in the platelet 
proteome, which confirmed our previous results that showed that platelets did not modify 
their CD41 protein level after thrombin activation. Moreover, although platelets are 
enucleated cells that lack their nucleus during the megakaryocytic cells cytoplasm 
fragmentation, it is well established that they conserve ribosomes, mRNAs, as well as the 
post-translationally modifying protein mechanisms (Dittrich et al., 2005). For this, we used a 
real time PCR to check if some change was produced in the αIIb transcripts level as a 
consequence of the platelet activation by thrombin. Results showed that although a small 
increase was detected, this was not statistically significant. It is well established that most 
changes produced after platelets activation involve post-translational modifications that 
affect the interactions between transmembrane and cytoplasmic domains of α and β chains 
(Russ & Engelman, 1999). So, our results support that the changes produced after thrombin 
platelet activation, which seems to disrupt the helical interface between the integrin α and β 
subunit transmembrane domains, favoring homomeric αIIb (and β3) transmembrane domain 
interactions in the αIIbβ3 receptor (Luo et al., 2004; Li et al., 2005; Partridge et al., 2005; Yin et 
al., 2006), must be produced by post-translational regulation, without affecting neither the 
transcript nor the protein level in the αIIb.   
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5. Conclusion  
Integrins are a family of heterodimeric transmembrane glycoproteins consiting of varying 
combinations of noncovalently bound α and β chains that generate several receptors with 
different expression patterns and ligand binding profiles. αIIbβ3 (CD41/CD61) integrin is the 
most abundant platelet receptor being responsible for the platelet aggregation. Most of the 
studies with  αIIbβ3 integrin have been carried out in humans and mice but little is known 
about the expression of αIIbβ3 integrin in porcine tissues, although pig is generally accepted 
as an optimal experimental model for different areas, as cardiovascular diseases, because of 
its similarity to humans. We have previously cloned and characterized the porcine gene 
coding for the  β3 (CD61) chain of the αIIbβ3 integrin; however, the one coding for αIIb (CD41) 
chain -the only α subunit for the β3 one- remained to be characterized.  
We describe in this chapter the molecular cloning, the structural and comparative analysis, 
and the expression patterns of the porcine gene coding for the αIIb integrin chain. 
Additionally, we also describe the chromosomal localization of the gene.  
We used a combined strategy of PCR and RACE reactions to obtain a full porcine αIIb cDNA 
sequence from platelet RNA. The pig αIIb cDNA was 3336-pb long and contained an ORF 
3111 b long that encodes a pre-αIIb protein composed by 1036 amino acid residues, from 
which, 961, 26 and 10 belong to the NH2-extracellular, the transmembrane and the 
cytoplasmic-COOH domains, respectively. The porcine αIIb shares with αIIb from other 
species: identical structure, a high % amino acid identity, common domains (α−Ι,  Ca++ 
binding, MIDAS), N-glycosylation sites, and the seven FG-GAP tandem repeats. However, 
in relation to other mammalian α chains, the porcine αIIb shares lower identities with those 
homologous in mammals (78% with humans, horses and cows, 78% with dogs, 75% with 
rabbits, 73% with mice and 71% with rats).  A phylogenetic tree identifies cows CD41 as the 
closest to pigs. 
By using both somatic cell hybrid and irradiated cell hybrid panels, we localized the gene 
coding for the porcine αIIb integrin in chromosome Sscr 12 region p11-(2/3 p13), in the same 
region where we previously localized the porcine β3 integrin gene, region that corresponds 
to the human homologous Hsap 17(q21) in chromosome 17.  
As expected, the porcine αIIb mRNAs were predominantly detected in platelets, but they 
were also detected in bone marrow and ganglion, in which platelets or megakaryocytes –the 
platelets precursors- were probably presents. To locate accurately the pattern expression of 
the αIIb protein, immunohistochemical, immunocytochemical and flow cytometry analysis 
were carried out. For this, monoclonal and polyclonal antibodies against porcine 
recombinant αIIb integrins (rαIIb) were previously produced. Citometry flow analysis 
determined the antibodies specificity for porcine platelets, being the first antibodies 
described with this characteristic. Immunohistochemical assays confirmed that the αIIb 
expression is restricted to the membranes of megacariocytes present in bone morrow. Flow 
cytometry analysis of PBC confirmed the αIIb expression in platelet but not in lymphocytes, 
erythrocytes or granulocytes.   
Finally, we checked by RT-Q-PCR if any change was produced in the level of αIIb 
transcripts in thrombin activated platelets, no detecting significant ones. This result, 
together to previous ones obtained by us, support that no change were produced in neither 
the transcript nor the protein level of αIIb, supporting αIIb post-translational changes in the 
αIIbβ3 platelet receptor after thrombin activation.  
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In conclusion, our results are of particular interest because the pig is an animal model 
system for a variety of immunological, developmental and pathological studies, and because 
αIIb integrin plays an essential role in phenomenons so significant as thrombosis, 
homeostasis, tumors progression and invasion, and differentiation of cells from the myeloid 
lineage in the bone marrow.  
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